References
- Futtlerweit W, Mechanick J I. Polycystic ovarian disease: etiology, diagnosis, and treatment. Compr Ther 1988; 14: 12–20
- Poison D W, Wadsworth J, Adams J, Franks S. Polycystic ovaries—a common finding in normal women. Lancet 1988; 1: 870–2
- Franks S. Polycystic ovary syndrome: a changing perspective. Clin Endocrinol 1989; 31: 87–120
- Dahlgren E, Friberg L ‐G, Johansson S, et al. Endometrial carcinoma; ovarian dysfunction—a risk factor in young women. Eur J Obstet Gynecol Reprod Biol 1991; 41: 143–150
- Insler V, Lunenfeld B. Pathophysiology of polycystic ovarian disease: new insights. Human Reprod 1991; 6: 1025–9
- Barblerl R L, Hornsteln M D. Hyperinsulinemia and ovarian hyperandrogenism. Endocrinol Metab Clin North Am 1988; 17: 685–703
- Dunaif A, Segal K R, Futterwelt W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165–74
- Chang R J, Nakamura R, Judd H L, Kaplan S A. Insulin resistance in non‐obese patients with polycystic ovarian disease. J Clin Endocrinol Metab 1983; 57: 356–9
- Kissebah A H, Vydellngum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254–60
- Burghen G A, Givens J R, Kitabchl A E. Correlation of hyperandrogenism and hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980; 50: 113–16
- Dahlgren E. Polycystic ovary syndrome: oncological and metabolic aspects. A clinical and epidemiological study. Thesis, University of Göteborg. 1992
- Lapldus L, Bengtsson C, Larsson B, Pennert K, Rybo G, Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 1984; 289: 1257–61